[D2 gastrectomy in the surgical treatment of gastric cancer].
The study is conducted on a series of 57 patients treated with D2 gastrectomy with curative intent for gastric cancer between January 2000 and December 2004, at Policlinico Multimedica (Milan). Postoperative mortality was 2%. Recurrence rate was 10%. The overall survival of the series is 36% at 4 years follow-up. Negative prognostic factors were: high grade tumor, locally advanced primary disease, presence of lymph node metastases, advanced stage of disease and recurrent disease at follow-up. The data of the study are comparable to those in the literature.
Ceriani
V
V
UO Chirurgia Generale, Policlinico Polispecialisticio MultiMedica, Sesto San Giovanni Milano.
Bignami
P
P
Faleschini
E
E
Lodi
T
T
Roncaglia
O
O
Osio
C
C
Sarli
D
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000601:surgery*